Your browser doesn't support javascript.
loading
Modification patterns and metabolic characteristics of m6A regulators in digestive tract tumors.
He, Bing; Hu, Yiyang; Chen, Hui; Xie, Xia; Gong, Chunli; Li, Zhibin; Chen, Yang; Xiao, Yufeng; Yang, Shiming.
  • He B; Department of Gastroenterology, Xinqiao Hospital, Army Military Medical University, Chongqing, 400037, China.
  • Hu Y; Department of Gastroenterology, Xinqiao Hospital, Army Military Medical University, Chongqing, 400037, China.
  • Chen H; Department of Gastroenterology, Xinqiao Hospital, Army Military Medical University, Chongqing, 400037, China.
  • Xie X; Department of Gastroenterology, Xinqiao Hospital, Army Military Medical University, Chongqing, 400037, China.
  • Gong C; Department of Gastroenterology, Xinqiao Hospital, Army Military Medical University, Chongqing, 400037, China.
  • Li Z; Department of Gastroenterology, Xinqiao Hospital, Army Military Medical University, Chongqing, 400037, China.
  • Chen Y; Department of Gastroenterology, Xinqiao Hospital, Army Military Medical University, Chongqing, 400037, China.
  • Xiao Y; Department of Gastroenterology, Xinqiao Hospital, Army Military Medical University, Chongqing, 400037, China.
  • Yang S; Department of Gastroenterology, Xinqiao Hospital, Army Military Medical University, Chongqing, 400037, China.
Heliyon ; 10(2): e24235, 2024 Jan 30.
Article en En | MEDLINE | ID: mdl-38298699
ABSTRACT
M6A is essential for tumor occurrence and progression. The expression patterns of m6A regulators differ in various kinds of tumors. Transcriptomic expression statistics together with clinical data from a database were analyzed to distinguish patients with digestive tract tumors. Based on the expression patterns of diverse m6A regulators, patients were divided into several clusters. Survival analysis suggested significant differences in patient prognosis among the m6A clusters. The results showed overlapping of m6A expression patterns with energy metabolism and nucleotide metabolism. Functional analyses imply that m6A modifications in tumor cells probably drive metabolic reprogramming to sustain rapid proliferation of cancer cells. Our analysis highlights the m6A risk characterizes various kinds of metabolic features and predicts chemotherapy sensitivity in digestive tract tumors, providing evidence for m6A regulators as markers to predict patient outcomes.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2024 Tipo del documento: Article